Monday, March 22, 2010 4:33:01 PM
Price To Earnings Ratio Trailing 12 Months: 6.080
Industry Average of P/E Trailing 12 Months: 52.25
Market Share Value / Earnings Per Share = P/E Ratio
$6.99 / $1.16 = $6.02
General sentiment through the P/E statistic shows the average trader will pay roughly $6 per $1 Earnings versus the average for the REIT field of $52.25 per $1 of earnings, which is a significantly reduced price.
Price To Sales Ratio Trailing 12 Months: 3.10
Industry Average of P/S Trail 12 Months: 5.48
Share Price / Revenue Per Share = P/E Ratio
$6.99 / $1.389 = $5.03
This basically shows a "Par" average across the board when compared to other companies within the REIT industry, it does not outshine any other company nor does it let you down compared to other companies, average is solid in my opinion here.
Price To Book Ratio 4th Quarter 2010: 0.94
Industry Average P/B 4th Quartr 2010: 2.54
Share Price / (Total Assets - Intangible assets and liabilities)
I didn't have time to find all the stuff required to get the above formula instead I just trusted what my broker reported as the appropriate number being 0.94 which shows a definitive undervaluing of the company under $7 per share.
----------------------------------------------------------------
Last Financial Statement Breakdown:
At December 31, 2009, Anworth had total assets of $6.53 billion. The Agency MBS portfolio, consisting of $6.49 billion, was distributed as 25% adjustable-rate Agency MBS, 62% hybrid adjustable-rate Agency MBS, 13% fixed-rate Agency MBS and less than 1% agency floating-rate collateralized mortgage obligations (CMO). The Non-Agency MBS portfolio consisted of approximately $4.7 million of floating-rate CMO's.
--------------------------------------------------------------
And I'm spent for the day, that's a productive day of research =)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM